News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Serentis Appoints Peter Keen as New Corporate Development and Finance Director



10/30/2007 9:14:54 AM

CAMBRIDGE, UK--(Marketwire - October 30, 2007) - Serentis, a UK-based biopharmaceutical company innovating, acquiring and developing dermatological and wound care products, announces today that it has appointed Peter Keen as Corporate Development and Finance Director.

Read at BioSpace.com


comments powered by Disqus
Serentis
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES